Everest Clinical Research Acquires Brightech International

December 2, 2022

Everest Clinical Research, a PE-backed full-service contract research organization, has acquired Brightech International, a specialist CRO focused on biostatistics, statistical programming, and clinical data management. The deal strengthens Everest's biometrics capabilities and global footprint, complementing its therapeutic strengths in Oncology, CNS, and Immunology.

Buyers
Everest Clinical Research, Arlington Capital Partners
Targets
Brightech International
Platforms
Everest Clinical Research
Location
New Jersey, United States
Transaction Type
Addon

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.